You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 1, January 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cataracts/ Lens
 •Alert me on articles by topic

Isolated Ectopia Lentis: Potential Role of Matrix Metalloproteinases in Fibrillin Degradation

Arch Ophthalmol. 2004;122:111-114.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Isolated ectopia lentis is a rare disorder in which no underlying cause for lens subluxation can be found, and it remains primarily a clinical diagnosis. Patients with this disorder may have a variety of ocular complaints, most commonly decreased vision due to lens subluxation.

Matrix metalloproteinases (MMPs) are proteolytic enzymes important in physiologic and pathologic connective tissue remodeling. Proteolytic activity is stringently controlled by a family of natural antagonists, the tissue inhibitors of metalloproteinases (TIMPs). The MMPs and TIMPs are present in the aqueous humor in normal eyes1 and may interact with the lens zonules.

We describe a patient with lens subluxation associated with positive MMP expression and no demonstrable TIMP immunoreactivity within the lens. To our knowledge, this is the first report of MMP activity, which we postulate leads to isolated ectopia lentis. Understanding the role of these proteases may lead to novel therapies to reduce the progressive nature . . . [Full Text of this Article]

Report of a Case


Results

Comment
Nitin H. Sachdev, MBChB; Minas T. Coroneo, MD, FRANZCO, FRACS; Denis Wakefield, MD, FRACP, FRCPA; Michael P. Hennessy, MBiomedE, FRANZCO
Sydney, Australia

Corresponding author: Michael P. Hennessy, MBiomedE, FRANZCO, Dept of Ophthalmology, Prince of Wales Hospital, University of New South Wales, Randwick, Sydney, Australia (e-mail: hennessymp@sesahs.nsw.gov.au).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Isolated Sulfite Oxidase Deficiency: A Case Report With a Novel Mutation and Review of the Literature
Tan et al.
Pediatrics 2005;116:757-766.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.